As Travelers Companies (TRV) Share Price Rose, Shareholder Iowa State Bank Trimmed Stake by $1.01 Million; Holder Healthcor Management LP Boosted Pacira Pharmaceuticals (PCRX) Holding

May 15, 2018 - By Darrin Black

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) Logo

Iowa State Bank decreased its stake in Travelers Companies Inc (TRV) by 25.05% based on its latest 2017Q4 regulatory filing with the SEC. Iowa State Bank sold 7,517 shares as the company’s stock rose 1.76% while stock markets declined. The institutional investor held 22,494 shares of the finance company at the end of 2017Q4, valued at $3.05 million, down from 30,011 at the end of the previous reported quarter. Iowa State Bank who had been investing in Travelers Companies Inc for a number of months, seems to be less bullish one the $35.16B market cap company. The stock increased 0.08% or $0.1 during the last trading session, reaching $130.1. About 711,704 shares traded. The Travelers Companies, Inc. (NYSE:TRV) has risen 13.01% since May 15, 2017 and is uptrending. It has outperformed by 1.46% the S&P500.

Arthur B Cohen increased its stake in Pacira Pharmaceuticals Inc (PCRX) by 8.61% based on its latest 2017Q4 regulatory filing with the SEC. Healthcor Management Lp bought 221,960 shares as the company’s stock declined 27.90% with the market. The hedge fund run by Arthur B Cohen held 2.80 million shares of the health care company at the end of 2017Q4, valued at $127.82 million, up from 2.58M at the end of the previous reported quarter. Healthcor Management Lp who had been investing in Pacira Pharmaceuticals Inc for a number of months, seems to be bullish on the $1.37B market cap company. The stock decreased 3.45% or $1.2 during the last trading session, reaching $33.6. About 199,839 shares traded. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has declined 33.05% since May 15, 2017 and is downtrending. It has underperformed by 44.60% the S&P500.

More important recent Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) news were published by: Globenewswire.com which released: “Pacira Pharmaceuticals to Present at Two Healthcare Conferences in May” on May 01, 2018, also Globenewswire.com published article titled: “Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results”, Seekingalpha.com published: “Pacira Pharmaceuticals (PCRX) Q1 2018 Results – Earnings Call Transcript” on May 03, 2018. More interesting news about Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) was released by: Streetinsider.com and their article: “Pacira Pharma (PCRX): CMS Decision for EXPAREL Still Awaited – RBC” with publication date: May 07, 2018.

Since December 15, 2017, it had 0 buys, and 2 sales for $1.18 million activity. $14,858 worth of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) was sold by Riker Lauren Bullaro.

Healthcor Management Lp, which manages about $3.20 billion and $3.07B US Long portfolio, decreased its stake in Boston Scientific Corp (NYSE:BSX) by 319,338 shares to 367,832 shares, valued at $9.12M in 2017Q4, according to the filing. It also reduced its holding in Neurocrine Biosciences Inc (NASDAQ:NBIX) by 562,110 shares in the quarter, leaving it with 1.53 million shares, and cut its stake in Livanova Plc.

Investors sentiment increased to 1.4 in 2017 Q4. Its up 0.01, from 1.39 in 2017Q3. It increased, as 29 investors sold PCRX shares while 41 reduced holdings. 31 funds opened positions while 67 raised stakes. 40.06 million shares or 3.76% less from 41.63 million shares in 2017Q3 were reported. Hightower Ltd Llc invested in 0% or 6,000 shares. 97,000 were accumulated by Kennedy Management Inc. Cornerstone Capital Mgmt Ltd holds 0% or 11,700 shares. The Ontario – Canada-based Commercial Bank Of Montreal Can has invested 0% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Tygh Cap Management stated it has 91,161 shares or 0.78% of all its holdings. Keybank National Association Oh stated it has 8,411 shares. Great West Life Assurance Can reported 0% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Plante Moran Limited Liability has invested 0.01% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Employees Retirement Association Of Colorado has 0.08% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for 281,588 shares. 37,895 are owned by Mirae Asset Glob Invs. Geode Management Ltd reported 421,237 shares. Teacher Retirement Systems Of Texas reported 0% stake. Element Capital Management Limited reported 134,584 shares. Piermont Capital Mngmt owns 6,500 shares. Evercore Wealth Mgmt Lc accumulated 0.01% or 3,409 shares.

Among 22 analysts covering Pacira Pharmaceuticals (NASDAQ:PCRX), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pacira Pharmaceuticals had 107 analyst reports since July 28, 2015 according to SRatingsIntel. Mizuho maintained it with “Hold” rating and $3100 target in Thursday, May 3 report. As per Monday, August 7, the company rating was maintained by Wedbush. The stock of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) earned “Outperform” rating by Wedbush on Wednesday, March 22. H.C. Wainwright maintained it with “Buy” rating and $45.0 target in Thursday, March 1 report. Canaccord Genuity maintained the shares of PCRX in report on Monday, May 29 with “Buy” rating. On Tuesday, May 3 the stock rating was maintained by Mizuho with “Buy”. Mizuho maintained Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) rating on Tuesday, July 25. Mizuho has “Buy” rating and $5400 target. Janney Capital maintained it with “Neutral” rating and $34 target in Friday, December 30 report. The firm has “Buy” rating given on Wednesday, July 19 by Wedbush. On Wednesday, June 29 the stock rating was initiated by BMO Capital Markets with “Underperform”.

More news for The Travelers Companies, Inc. (NYSE:TRV) were recently published by: Streetinsider.com, which released: “Viking Global’s 13F Shows New Stakes in Alibaba (BABA), BioMarin (BMRN) and Western Digital (WDC), Increase in …” on May 15, 2018. Seekingalpha.com‘s article titled: “Travelers: A Dividend Growth Machine” and published on April 25, 2018 is yet another important article.

Analysts await The Travelers Companies, Inc. (NYSE:TRV) to report earnings on July, 19. They expect $2.43 EPS, up 26.56% or $0.51 from last year’s $1.92 per share. TRV’s profit will be $656.75 million for 13.38 P/E if the $2.43 EPS becomes a reality. After $2.46 actual EPS reported by The Travelers Companies, Inc. for the previous quarter, Wall Street now forecasts -1.22% negative EPS growth.

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>